The loss of p16 (INK4A) protein expression can be detected in 45% of cardiac, esophageal, and gastric adenocarcinoma and correlates with p16 (INK4A) gene hypermethylation. The gene discussed is CDKN2A; the disease is gastric adenocarcinoma.